What question did this study set out to answer?

To evaluate the efficacy of telemedicine interventions on glycemic control and secondary clinical outcomes across pooled type 1 and type 2 diabetes populations, comparing differences in treatment benefit.

October 28, 2020Journal of Medical Internet ResearchOpen Access

Clinical Improvements by Telemedicine Interventions Managing Type 1 and Type 2 Diabetes: Systematic Meta-review

View Full Paper

Ask AI

Bookmark

Authors

CEClaudia EberleFulda University of Applied Sciences SSStefanie StichlingFulda University of Applied Sciences

Discussion

Member takes

Implication

Systematic meta-review demonstrates significant reductions in HbA1c following telemedicine interventions in diabetes, suggesting greater glycemic benefits for type 2 than type 1 diabetes.

Key Points

To evaluate the efficacy of telemedicine interventions on glycemic control and secondary clinical outcomes across pooled type 1 and type 2 diabetes populations, comparing differences in treatment benefit.
Searched Cochrane Library, MEDLINE, Web of Science Core Collection, Embase, and CINAHL from January 2008 to April 2020 for systematic reviews, meta-analyses, and clinical trials.
Identified 31 eligible publications (21 systematic reviews/meta-analyses, 8 RCTs, 1 non-RCT, 1 qualitative study) and categorized trials into real-time, asynchronous, or combined interventions.
Telemedicine interventions produced significant reductions in pooled HbA1c, ranging from a weighted mean difference of −0.22% (95% CI −0.28 to −0.15; P<.001) to a mean difference of −0.64% (95% CI −1.01 to −0.26; P<.001).
Reductions in HbA1c were significantly smaller in patients with type 1 diabetes mellitus compared with patients with type 2 diabetes mellitus.
Evidence regarding secondary endpoints—including blood pressure, body weight, fasting blood glucose, cost effectiveness, and time savings—showed smaller and less consistent effects than HbA1c.

Cite This Study

Eberle et al. (2020) studied this question.

synapsesocial.com/papers/6a704fe65d37378ac1dd63af https://doi.org/10.2196/23244

View Full Paper

Ask AI

Bookmark

Implication

Systematic meta-review demonstrates significant reductions in HbA1c following telemedicine interventions in diabetes, suggesting greater glycemic benefits for type 2 than type 1 diabetes.

Clinical Improvements by Telemedicine Interventions Managing Type 1 and Type 2 Diabetes: Systematic Meta-review

Discussion

Member takes

Implication

Key Points

Cite This Study

Clinical Improvements by Telemedicine Interventions Managing Type 1 and Type 2 Diabetes: Systematic Meta-review

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider